Sienna Diagnostics Inks New Distribution Deal for Bladder Cancer Test

Jan 22, 2019

|

NEW YORK (360Dx) — Sienna Cancer Diagnostics said today that it has signed a South Korean distribution agreement for its bladder cancer diagnostic with Mirax.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Sienna Diagnostics Inks New Distribution Deal for Bladder Cancer Test

To read the full story....

Breaking News

OraSure Technologies Q4 Revenues Rise 27 Percent, Beat Analysts' Estimate

CMS Releases New Guidance Requiring Payors to Cover COVID-19 Testing Without Cost Sharing

UPDATED: Quidel At-Home, Rapid Antigen, COVID-19 Test Gets FDA Emergency Use Authorization

FDA Reissues EUA for Fluidigm SARS-CoV-2 Test for Use With Azova Home Collection Kit

Eurofins Scientific Posts 17 Percent Increase in FY2020 Revenues

OpGen Unyvero IVD Platform Nabs Chinese Regulatory Approval

Featured White Papers

What's Popular?

Bio-Techne Obtains Reimbursement Contract With Humana for Exosome Diagnostics Prostate Biopsy Test

Guardant Health Begins First Foray Into Early-Stage Cancer With Commercial MRD Test Launch

Natera Launches Tumor Genomic Profiling Assay, Expects Reproductive Health to Break Even This Year

AMP Survey Finds Significant Decline in Molecular Cancer Testing Due to COVID-19 Pandemic

Natera Revenues Grow 35 Percent in Q4

Sponsorships